Phase 4
Completed N=11
Hypothyroidism Treated With Calcitonin
Source: ClinicalTrials.gov NCT03342001 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Modified City of Hope Quality of Life Questionnaire for Patients With Thyroid Disease — -36.33 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Some people with hypothyroidism have persistent symptoms despite adequate treatment with thyroid hormones. We are testing whether giving calcitonin to such people will improve their quality of life.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Modified City of Hope Quality of Life Questionnaire for Patients With Thyroid Disease |
-36.33 | — |
Eligibility Criteria
Inclusion Criteria
- Normal TSH on levothyroxine therapy
Exclusion Criteria
- pregnant or 6 months post partum
- Current or previous thyroid cancer
- Congenital hypothyroidism
- any tobacco use
- prescribed proton pump inhibitors
- prescribed steroids
- taking armour thyroid, naturethroid, or any dessicated thyroid hormone
- Unstable medical conditions (CKD, Cirrhosis etc)
- pituitary disease
Data sourced from ClinicalTrials.gov (NCT03342001). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.